Equities researchers at UBS Group initiated coverage on shares of Danaher (NYSE:DHR) in a note issued to investors on Monday, January 22nd, 247wallst.com reports. The firm set a “buy” rating and a $99.97 price target on the conglomerate’s stock. UBS Group’s price target points to a potential upside of 5.25% from the company’s current price.
A number of other brokerages have also recently weighed in on DHR. Citigroup raised their price target on Danaher to $107.00 and gave the company a “buy” rating in a research report on Friday, December 15th. Robert W. Baird restated a “buy” rating on shares of Danaher in a research report on Friday, January 12th. Goldman Sachs Group restated a “neutral” rating and issued a $83.00 price target on shares of Danaher in a research report on Tuesday, September 26th. Royal Bank of Canada restated a “hold” rating and issued a $96.00 price target on shares of Danaher in a research report on Thursday, January 4th. Finally, Credit Suisse Group raised their price target on Danaher from $93.00 to $96.00 and gave the company an “outperform” rating in a research report on Friday, October 20th. One analyst has rated the stock with a sell rating, five have issued a hold rating, fourteen have given a buy rating and one has assigned a strong buy rating to the stock. The stock currently has an average rating of “Buy” and an average price target of $100.13.
Shares of Danaher (DHR) opened at $94.98 on Monday. The company has a current ratio of 1.43, a quick ratio of 1.05 and a debt-to-equity ratio of 0.39. Danaher has a fifty-two week low of $78.97 and a fifty-two week high of $104.82. The firm has a market capitalization of $66,462.61, a price-to-earnings ratio of 23.67, a P/E/G ratio of 2.01 and a beta of 1.04.
Danaher (NYSE:DHR) last released its earnings results on Tuesday, January 30th. The conglomerate reported $1.19 EPS for the quarter, beating analysts’ consensus estimates of $1.16 by $0.03. Danaher had a return on equity of 11.36% and a net margin of 13.60%. The company had revenue of $5.09 billion during the quarter, compared to the consensus estimate of $4.97 billion. During the same quarter last year, the company earned $1.05 earnings per share. Danaher’s quarterly revenue was up 10.9% compared to the same quarter last year. analysts anticipate that Danaher will post 4.37 EPS for the current year.
In other Danaher news, SVP Angela S. Lalor sold 42,988 shares of the firm’s stock in a transaction dated Friday, February 2nd. The stock was sold at an average price of $102.29, for a total value of $4,397,242.52. Following the sale, the senior vice president now directly owns 82,008 shares of the company’s stock, valued at approximately $8,388,598.32. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, EVP William K. Daniel sold 131,066 shares of the firm’s stock in a transaction dated Friday, February 2nd. The stock was sold at an average price of $102.05, for a total value of $13,375,285.30. Following the completion of the sale, the executive vice president now directly owns 270,523 shares in the company, valued at $27,606,872.15. The disclosure for this sale can be found here. In the last quarter, insiders have sold 274,913 shares of company stock valued at $27,729,293. 12.20% of the stock is currently owned by company insiders.
A number of large investors have recently modified their holdings of the business. ETRADE Capital Management LLC lifted its stake in shares of Danaher by 5.1% in the 2nd quarter. ETRADE Capital Management LLC now owns 19,075 shares of the conglomerate’s stock valued at $1,610,000 after purchasing an additional 917 shares in the last quarter. Roundview Capital LLC lifted its position in Danaher by 2.0% during the 2nd quarter. Roundview Capital LLC now owns 25,674 shares of the conglomerate’s stock worth $2,167,000 after acquiring an additional 502 shares in the last quarter. Honeywell International Inc. lifted its position in Danaher by 113.4% during the 3rd quarter. Honeywell International Inc. now owns 640,100 shares of the conglomerate’s stock worth $54,908,000 after acquiring an additional 340,100 shares in the last quarter. Veritable L.P. lifted its position in Danaher by 28.2% during the 2nd quarter. Veritable L.P. now owns 40,486 shares of the conglomerate’s stock worth $3,417,000 after acquiring an additional 8,912 shares in the last quarter. Finally, Wealthfront Inc. lifted its position in Danaher by 10.2% during the 2nd quarter. Wealthfront Inc. now owns 14,574 shares of the conglomerate’s stock worth $1,230,000 after acquiring an additional 1,348 shares in the last quarter. 75.88% of the stock is currently owned by hedge funds and other institutional investors.
ILLEGAL ACTIVITY WARNING: “Danaher (NYSE:DHR) Coverage Initiated at UBS Group” was first published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this article on another publication, it was illegally stolen and reposted in violation of United States & international trademark & copyright legislation. The correct version of this article can be read at https://www.dispatchtribunal.com/2018/02/14/danaher-dhr-coverage-initiated-at-ubs-group.html.
Danaher Company Profile
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.